Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04926974
Other study ID # CARE
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 2, 2021
Est. completion date September 29, 2023

Study information

Verified date October 2023
Source New England College of Optometry
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Study is a randomized clinical trial evaluating the efficacy of novel mobile application technologies (including Seeing AI, Aira, and Supervision+) to improve quality of life in older adults with low vision by expanding community access and providing assistance with activities of daily living. Aira provides real-time remote personal assistance through a sighted Aira agent supplying direct feedback to assist with visual tasks. Seeing AI provides optical character recognition allowing any text to be read aloud, color identification, bar code reading, scene description, and facial recognition based on stored photos. Supervision + allows one to use the phone as a magnifier, providing magnification and contrast enhancement using the camera of the mobile phone. This study seeks to understand the potential of these technologies to improve daily activities, community participation, independence, and self-sufficiency in this group by examining a technological approach, which has not yet undergone rigorous investigation in a diverse population of older adults with visual impairment. Project objectives are to evaluate mobile applications in a wide range of visual disability, categorized into three groups: (1) mild to moderate visual acuity loss, (2) severe to profound visual acuity loss, and (3) legal blindness secondary to visual field loss. Participants are randomized to one of three intervention groups: (1) Supervision+ application, (2) Aira application, or (3) Seeing AI application for a period of 6 months. For the Aira intervention group, participants will be assigned either with 'restricted' access (current open access areas plus 30 minutes/month anywhere), or 'unrestricted' access (700 minutes), for a period of 3 months with a 3 month cross-over period. Participants may elect to continue the study for an additional 3 months during which time they have access to all 3 study mobile applications. Outcome measures include assessment of changes at three, six and nine months post-intervention for: visual ability, health state (including depression), self-efficacy, loneliness, life space, distances travelled from the home, and types of services obtained.


Recruitment information / eligibility

Status Completed
Enrollment 145
Est. completion date September 29, 2023
Est. primary completion date September 29, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 55 Years and older
Eligibility Inclusion Criteria: - age 55 years + (no upper limit) - reside in CA state (for subjects enrolled at UCLA) - reside in New England states of MA, NH, CT or RI (for subjects enrolled at NECO) - best-corrected visual acuity 20/40 to 20/800 in the better eye or visual field diameter less than 20 degrees in the better eye - English speaking - Ability to demonstrate proficiency with the smartphone and mobile app at 4 weeks post initial training - no previous use of the Aira app, Seeing AI app or Super Vision+ app on a smartphone (<5 uses in lifetime) Exclusion Criteria: - out of the country for >2 weeks during study intervention period if cannot use their own international data plan on their own phone - unable to successfully complete the initial on-boarding call for Aira service with an agent as documented by the Aira agent's log (if randomized to Aira) - schedules not permitting participation in planned study duration (including planning to move or take extended vacation during study period) - inability to understand study procedures or communicate responses in a consistent manner (cognitive impairment as per TICS) - substance abuse - significant hearing loss (unable to hear communication by phone) - significant medical condition likely to limit participation or lifespan - participating in another clinical trial that involves treatment that could impact visual function during the study period - participant in another clinical trial that involves a treatment or intervention that could impact visual functioning - begins use of a new vision-related app during the trial period for the study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Low Vision Rehabilitation
Smart phone App

Locations

Country Name City State
United States New England College of Optometry Boston Massachusetts
United States UCLA Stein Eye Institute Los Angeles California

Sponsors (3)

Lead Sponsor Collaborator
New England College of Optometry National Institute on Disability, Independent Living, and Rehabilitation Research, University of California, Los Angeles

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Telephone Interview of Cognitive Status (TICS) questionnaire; with subscales 0 to 1, with higher scores indicating greater cognitive ability. administered at time of enrollment
Other Psychosocial Impact of Assistive Devices Scale (PIADS) questionnaire; with subscales from -3 to 3, higher scores indicate greater affinity of a particular factor to assistive technology use. administered at 3-months post-intervention and 6-months post-intervention and also 9 months post-intervention
Other Aira Explorer Survey post intervention feedback (specific to those participants randomized to Aira); questionnaire, with subscales ranging from 0 to 10, higher scores indicate stronger agreement or helpfulness of the Aira App. 6 months and also 9 months post-intervention
Primary Visual ability change score The primary outcome measure is the person change score (before and after intervention), from the adaptive Massof Activity Inventory (AI) Questionnaire. The AI has an item bank of 510 items organized into 50 goals and 460 related visually-based tasks. Subscales range from 0 (not important) to 3 (very important). For those goals rated as important, subjects are asked to rate the task difficulty on subscales of 0 (impossible to do without help) to 5 (not difficult). Rasch analysis is employed to estimate visual ability from these difficulty ratings, on an interval scale. With Rasch analysis person measures are estimated, whereby a more positive person measure reflects greater visual ability.
In this study, we will explore the the difference in person measures (i.e. change score) after the intervention at 3 and 6 months. A larger, more positive change score indicates greater visual ability since intervention.
AI questionnaire will be administered three times over 6 months: baseline, 3-months post-intervention and 6-months post-intervention, and also 9 months post-intervention
Secondary Health-related Quality of Life: SF-36 questionnaire; scale ranges from 1 (excellent) to 5 (poor), with higher values indicating greater difficulty. will be administered three times over 6 months: baseline, 3-months post-intervention and 6-months post-intervention and also 9 months post-intervention
Secondary Beck Depression Inventory questionnaire; subscales range from 0 to 3, with higher values indicating greater depression. will be administered three times over 6 months: baseline, 3-months post-intervention and 6-months post-intervention and also 9 months post-intervention
Secondary Community Living: Life Space Questionnaire questionnaire; subscales range from 1 (Yes) to 2 (No), with a higher total value indicating a more restricted life space. will be administered three times over 6 months: baseline, 3-months post-intervention and 6-months post-intervention and also 9 months post-intervention
Secondary 3-item UCLA Loneliness Scale questionnaire; subscales range from 1 to 3, with a high value indicating increased loneliness. will be administered three times over 6 months: baseline, 3-months post-intervention and 6-months post-intervention and also 9 months post-intervention
Secondary New General Self Efficacy Scale questionnaire; subscales range from 1 to 5, with a higher value indicating greater self-efficacy. will be administered three times over 6 months: baseline, 3-months post-intervention and 6-months post-intervention and also 9 months post-intervention
Secondary App usage frequency App usage in minutes. at 3 months post-intervention and 6 months post intervention and also 9 months post-intervention
See also
  Status Clinical Trial Phase
Recruiting NCT04929756 - Eye Movement Rehabilitation in Low Vision Patients
Completed NCT04974307 - Optic-to-Audio Device in a Pediatric Cohort With CLN3-related Conditions or Low Vision N/A
Completed NCT02310880 - Efficacy of Enhancing Low Vision Mobility Thru Visual Training in Virtual World N/A
Terminated NCT04040790 - Performance of Rigid Gas Permeable (RGP) Scleral Contact Lenses With a Passive Artificial Iris N/A
Recruiting NCT06107881 - Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST-AID) for Low Vision N/A
Completed NCT00545220 - Problem Solving Training and Low Vision Rehabilitation N/A
Recruiting NCT04066075 - Beacon Sensors and Telerehabilitation for Low Vision N/A
Recruiting NCT04281732 - Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision
Completed NCT01217502 - Self-management for Dual Sensory Impaired N/A
Completed NCT00946062 - Evaluation of a Standardised Orientation and Mobility Training in Older Adults With Low Vision N/A
Terminated NCT04276610 - Words on the Brain: Can Reading Rehabilitation for Age-Related Vision Impairment Improve Cognitive Functioning? N/A
Recruiting NCT05829135 - Improving Glare and Visual Comfort for Patients With Visual Impairment N/A
Completed NCT04242836 - Development and Validation of a Digital Optotype for Near Vision in Greek Language.
Terminated NCT03353727 - Orthoptic Rehabilitation for Low Vision People With Innovative Mechanisms (Eye Tracker and Tactile Device) N/A
Completed NCT00348621 - A Study of Interventions to Reduce Disability From Visual Loss in Nursing Home Residents Phase 4
Not yet recruiting NCT03104608 - Automatic Self Transcending Meditation (ASTM) for Patients With Severe Age Related Macular Degeneration (AMD) N/A
Completed NCT05491746 - Diabetic Retinopathy Tethered Augmented Reality With Eye4 Study N/A
Completed NCT03728660 - Design and Clinical Evaluation of a Smartphone-based Low Vision Enhancement System N/A
Completed NCT05209581 - Assessment of Visual Acuity in Refugee Population
Recruiting NCT01879501 - Living Successfully With Chronic Eye Diseases N/A